MedPath

Feasibility and efficacy of the de-escalation therapy by Biapenem for postoperative bacterial pneumonia.

Not Applicable
Recruiting
Conditions
postoperative pneumonia after esophagectomy for esophageal cancer
Registration Number
JPRN-UMIN000017219
Lead Sponsor
Department of Gastrointestinal Surgery, The University of Tokyo Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Other infectious disease including SSI is present. History of hyper reactive events caused by carbapenem. The suspected pathogenic microbes of the pneumonia is; MRSA, MDRP, virus, mycoplasma, regionera, clmamigia, MAC, yeast. MRSA or MDRP is present in any culture specimen during the in hospital course. History of epilepsy or barproic acid use. Renal disease with Ccr lower than 20ml/kg.min or requiring hemodialysis.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Days required for the treatment of Biapenem Postoperative hospital stay
Secondary Outcome Measures
NameTimeMethod
Clinical and bacteriological efficacy rates at each time point during the use of Biapanem.
© Copyright 2025. All Rights Reserved by MedPath